Viewing StudyNCT00462202



Ignite Creation Date: 2024-05-05 @ 5:29 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00462202
Status: TERMINATED
Last Update Posted: 2017-03-03
First Post: 2007-04-16

Brief Title: Open Label Tolerability and Safety Study of KRX-101 in Australia New Zealand and Hong Kong
Sponsor: Keryx Biopharmaceuticals
Organization: Keryx Biopharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Diabetic Nephropathy
Keywords:
Name View
Diabetic nephropathy with persistent microalbuminuria View
Diabetes View
Microalbuminuria View
Proteinuria View
Albuminuria View
KRX-101 View
Sulodexide View
Nephropathy View
Keryx View
Collaborative Study Group View